TickerFactsScreenerDevelopers

Lexaria Bioscience Corp. (LEXX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$330.3K2011: $109.8K2012: $135.9K2013: $321.0K2014: -$515.8K2015: -$1.50M2016: -$660.9K2017: -$1.55M2018: -$2.52M2019: -$3.01M2020: -$2.62M2021: -$3.99M2022: -$4.88M2023: -$5.88M2024: -$4.96M2025: -$10.45M-$10.45M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.45M-110.7%
2024-$4.96M+15.7%
2023-$5.88M-20.5%
2022-$4.88M-22.3%
2021-$3.99M-52.3%
2020-$2.62M+12.9%
2019-$3.01M-19.4%
2018-$2.52M-62.9%
2017-$1.55M-133.9%
2016-$660.9K+56.0%
2015-$1.50M-191.0%
2014-$515.8K-260.7%
2013$321.0K+136.1%
2012$135.9K+23.8%
2011$109.8K+133.3%
2010-$330.3K—